MedPath

Optimizing Breathing and Blood Flow in Patients Treated With VA ECMO

Not Applicable
Not yet recruiting
Conditions
VA-ECMO
Registration Number
NCT07141524
Lead Sponsor
Beth Israel Deaconess Medical Center
Brief Summary

The aim of this study is to characterize ventilation/perfusion (V/Q) matching in adult patients receiving peripheral VA ECMO support while on mechanical ventilation, and to evaluate the impact of PEEP titration guided by Electrical Impedance Tomography (EIT) and esophageal pressure measurements on lung mechanics and V/Q optimization.

Detailed Description

We hypothesize that an individualized PEEP titration guided by esophageal pressure measurements and Electrical Impedance Tomography can reduce lung overdistention, enhance lung recruitment, and improve V/Q matching by optimizing regional ventilation and perfusion also in VA ECMO.

Our objectives are:

1. To describe V/Q matching in patients undergoing mechanical ventilation during peripheral VA ECMO support.

2. To explore the impact of PEEP titration based on esophageal pressure and EIT in terms of lung mechanics and V/Q matching.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Adults (≥18 years) undergoing mechanical ventilation during peripheral VA ECMO support for cardiogenic shock, cardiac arrest, or refractory heart failure.
  • On ECMO support for at least 6 hours
  • Swan-Ganz catheter required as standard clinical care
  • Clinically stable in the estimation of the study investigator
Exclusion Criteria
  • Contraindications to EIT (e.g., presence of pacemaker or IMPELLA device for electrical interference)
  • Patients without pulmonary flow (non-pulsatile pulmonary prSessure)
  • Patients with known pulmonary embolism
  • Imminent withdrawal of life support

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
V/Q match1 hour

The primary goal of this physiological study is to measure improvements in ventilation-perfusion matching and quantify shunt fraction. The study aims to document measurable changes expressed as a percentage improvement from baseline.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Beth Israel Deaconess Medical Center

🇺🇸

Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center
🇺🇸Boston, Massachusetts, United States
Arian Karimitar, PhD
Contact
6176328056
akarimit@bidmc.harvard.edu
Maurizio Bottiroli, MD
Contact
6176673112
mbottiro@bidmc.harvard.edu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.